U.S. Residents Only, 18 Years and Older.
HOME
|
CONTACT US
|
INDEX
BMS.com-US
Study Connect Home
About Clinical Studies
What is a clinical study?
Who can participate?
Are there any risks to participants?
What investigational drug names are used in clinical study listings
Understanding clinical study phases
What is Informed Consent?
How are participants protected?
Clinical Study Insights
Pediatric Clinical Studies
Why are pediatric clinical studies important?
Video Gallery: What people are saying
Informed consent in pediatric studies
Caregivers
Some considerations for caregivers of study participants
Informed consent for caregivers
Caregiver resources
Clinical Study FAQs
Study ID (Protocol Number)
CA209-057
STUDY LOCATIONS*
Chattanooga Oncology Hematology Associates
Chattanooga, TN 37404
Recruiting
Donald Guthrie Foundation
Sayre, PA 18840
Recruiting
Columbia Basin Hematology And Oncology
Kennewick, WA 99336
Recruiting
Duke University Medical Center
Durham, NC 27710
Recruiting
*Not all study site locations may be listed - please check back soon for updated
information. For more information regarding other participating countries, please
visit
clinicaltrials.gov
.
STUDY NAME
Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or
Metastatic
Non-squamous
NSCLC
STUDY OVERVIEW
The purpose of the study is to compare the overall survival of BMS-936558 as compared with Docetaxel in
subjects
with non-
squamous cell
non-small cell lung cancer
(NSCLC) after failure of prior platinum-based
chemotherapy
The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit
ClinicalTrials.gov
for complete information about this and other clinical studies.